WO2002026815A3 - Identification of neuroblastoma tumor suppressor genes - Google Patents

Identification of neuroblastoma tumor suppressor genes Download PDF

Info

Publication number
WO2002026815A3
WO2002026815A3 PCT/EP2001/011199 EP0111199W WO0226815A3 WO 2002026815 A3 WO2002026815 A3 WO 2002026815A3 EP 0111199 W EP0111199 W EP 0111199W WO 0226815 A3 WO0226815 A3 WO 0226815A3
Authority
WO
WIPO (PCT)
Prior art keywords
tumor suppressor
identification
suppressor genes
neuroblastoma tumor
neuroblastoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/011199
Other languages
French (fr)
Other versions
WO2002026815A2 (en
Inventor
Roy Frans Van
Frank Speleman
Katrien Staes
Karl Vandepoele
Roy Nadine Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vlaams Instituut voor Biotechnologie VIB
Original Assignee
Vlaams Instituut voor Biotechnologie VIB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Instituut voor Biotechnologie VIB filed Critical Vlaams Instituut voor Biotechnologie VIB
Priority to US10/381,906 priority Critical patent/US20040132030A1/en
Priority to CA002422099A priority patent/CA2422099A1/en
Priority to AU2002223568A priority patent/AU2002223568A1/en
Priority to EP01985712A priority patent/EP1339841A2/en
Publication of WO2002026815A2 publication Critical patent/WO2002026815A2/en
Anticipated expiration legal-status Critical
Publication of WO2002026815A3 publication Critical patent/WO2002026815A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a new tumor suppressor gene family. More specifically the present invention relates to a tumor suppressor involved in suppression of neuroblastoma. Said tumor suppressor is involved in the generation of micronuclei and in the removal of acentric chromosomal fragments that might contain amplified DNA.
PCT/EP2001/011199 2000-09-27 2001-09-27 Identification of neuroblastoma tumor suppressor genes Ceased WO2002026815A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/381,906 US20040132030A1 (en) 2000-09-27 2001-09-27 Identification of neuroblastoma tumor suppressor genes
CA002422099A CA2422099A1 (en) 2000-09-27 2001-09-27 Identification of neuroblastoma tumor suppressor genes
AU2002223568A AU2002223568A1 (en) 2000-09-27 2001-09-27 Identification of neuroblastoma tumor suppressor genes
EP01985712A EP1339841A2 (en) 2000-09-27 2001-09-27 Identification of neuroblastoma tumor suppressor genes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00870219.3 2000-09-27
EP00870219 2000-09-27

Publications (2)

Publication Number Publication Date
WO2002026815A2 WO2002026815A2 (en) 2002-04-04
WO2002026815A3 true WO2002026815A3 (en) 2003-06-19

Family

ID=8175818

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011199 Ceased WO2002026815A2 (en) 2000-09-27 2001-09-27 Identification of neuroblastoma tumor suppressor genes

Country Status (5)

Country Link
US (1) US20040132030A1 (en)
EP (1) EP1339841A2 (en)
AU (1) AU2002223568A1 (en)
CA (1) CA2422099A1 (en)
WO (1) WO2002026815A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2858688A1 (en) 2011-12-08 2013-06-13 Five3 Genomics, Llc Mdm2-containing double minute chromosomes and methods therefore

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279294B2 (en) * 2000-04-03 2007-10-09 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services, Nih Tumor markers in ovarian cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 22 May 2000 (2000-05-22), PAVITT R.: "Human DNA sequence. Chromosome 1", XP000216422, Database accession no. AL356581 *
DATABASE EMBL 12 March 2000 (2000-03-12), BLOECKER H., ET AL: "Homo sapiens mRNA; EST DKFZp434M0628_r1", XP002229959, Database accession no. AL044107 *
NAGASE T ET AL: "PREDICTION OF THE CODING SEQUENCES OF UNIDENTIFIED HUMAN GENES. XV. THE COMPLETE SEQUENCES OF 100 NEW CDNA CLONES FROM BRAIN WHICH CODE FOR LARGE PROTEINS IN VITRO", DNA RESEARCH, UNIVERSAL ACADEMY PRESS, JP, vol. 6, 1999, pages 337 - 345, XP000865804, ISSN: 1340-2838 *
ROY VAN N ET AL: "ANALYSIS OF 1;17 TRANSLOCATION BREAKPOINTS IN NEUROBLASTOMA: IMPLICATIONS FOR MAPPING OF NEUROBLASTOMA GENES", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 33, no. 12, 1997, pages 1974 - 1978, XP000990818, ISSN: 0959-8049 *
See also references of EP1339841A2 *

Also Published As

Publication number Publication date
CA2422099A1 (en) 2002-04-04
US20040132030A1 (en) 2004-07-08
AU2002223568A1 (en) 2002-04-08
WO2002026815A2 (en) 2002-04-04
EP1339841A2 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
AU2001273548A1 (en) Photoselection of nucleic acid ligands
AU2002367466A1 (en) Amplification of nucleic acid fragments using nicking agents
AU2002238418A1 (en) Use of DNA repair enzymes as MMP-1 inhibitors
AU2001278783A1 (en) Method of amplifying nucleic acid
WO2001068146A3 (en) Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
WO1999057325A3 (en) Enzymes mixture
AU2002365811A1 (en) Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2001285219A1 (en) Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
WO2002044360A3 (en) Modified arginine deiminase
AU2756301A (en) Compositions comprising genome segments and methods of using the same
WO2002026815A3 (en) Identification of neuroblastoma tumor suppressor genes
AU2001266666A1 (en) Direct enzyme agglomeration process
AU6795201A (en) Nucleic acid sequences and methods for the modification of plant gene expression
WO2001036679A3 (en) METHODS FOR GENERATING SINGLE STRANDED cDNA FRAGMENTS
AU2002212678A1 (en) Methods of quantitative detection of genetic recombinants and standard molecules for the methods.
AU5642000A (en) Self-induced deletion of dna
AU2002307503A1 (en) Methods to identify agents that bind the flap-tip helix of rna polymerase
AU6424501A (en) Novel enzyme gene and its expression product
AU2001264245A1 (en) Novel enzyme gene and its expression product
AU2001296274A1 (en) Isolated genomic polynucleotide fragments from chromosome 7
AU2002229011A1 (en) Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
AU2002305068A1 (en) Compositions and methods to prevent metastasis from primary malignancies
AU2003284787A1 (en) Inhibitor of angiogenesis and kit for treating cancer comprising the inhibitor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2422099

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001985712

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10381906

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001985712

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP